Josephine Amalia Taverna, M.D.
Medical Oncology Physician · San Antonio, TX
Josephine Amalia Taverna, M.D. is a medical oncology physician with a practice address in San Antonio, Texas, and NPI 1629283833, issued on May 11, 2007. Check the license (Texas R5478, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Josephine Amalia Taverna
- Credential
- M.D.
- Primary taxonomy
- Medical Oncology Physician 207RX0202X
- License numbers
- R5478 TX
57.017321 OH
Self-reported in NPPES; status is on the state search - Practice location
- 7979 Wurzbach RD FL 4, San Antonio, TX 78229
- Phone
- (210) 450-1143
- Enumerated
- May 11, 2007
- Record last updated
- Mar 17, 2018 (not updated in 8 years: call before relying on the address or phone)
- Fax
- (210) 450-0407
- Medicaid ID
- 378896001 TX
- Medicare enrollment
- Enrolled (PECOS I20171218000189); accepts Medicare assignment
- Entity
- Type 1 · individual
8 nearest medical oncology physician records → All 547 in Texas → Look up another NPI →
Verify Josephine Amalia Taverna in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license R5478Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
37% fewer Medicare Part D claims than the average medical oncology physician in 2024
442 Medicare Part D claims for 48 beneficiaries, against an average of 703 among the 4,230 providers of this specialty who prescribed in Part D. Brand-name drugs were 29% of claims.
Most prescribed
- Tagrisso67 claims
- Ondansetron Hcl49 claims
- Dexamethasone45 claims
- Prochlorperazine Maleate45 claims
- Olanzapine40 claims
- Gabapentin24 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $387.87
6 payments; by number, the most common kind was food and beverage; the largest payer was E.R. Squibb & Sons, L.L.C. The 3,343 providers of this specialty with any payment received $11,773.47 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- University OF Texas Health Science Center AT San AntonioSan Antonio, TX
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Josephine Amalia Taverna among 547 medical oncology physician records in Texas
Josephine Amalia Taverna, M.D. is one of 547 medical oncology physician records with a practice address in Texas. 85% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2007, is newer than 55% of them.
- NPI issued2007 · 55% of these records are older, 34% newer
- In a Medicare fileYes · 85% of these records are
- In the CMS Doctors and Clinicians fileYes · 76% of these records are
- Graduated2004 · median 2000 among the 414 with a school on file
- Record last updated2018 · 62% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RX0202X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Medical Oncology Physician providers in Texas
There are 547 medical oncology physician records in Texas.
All 547 in Texas → Every provider in San Antonio → Medical Oncology Physician nationwide →
The 8 medical oncology physician records with the nearest ZIP codes
- Muralidhar Beeram, M.D.San Antonio, TX 782291265426282
- Ronald Drengler, M.D.San Antonio, TX 782291265459168
- Virginia Kaklamani, MDSan Antonio, TX 782291841235439
- Anand Karnad, M.D.San Antonio, TX 782291023011624
- Amy Lang, M.D.San Antonio, TX 782291104850486
- Charles Lemaistre, M.D.San Antonio, TX 782291033176946
- Daruka Mahadevan, MD, PHDSan Antonio, TX 782291841398302
- Robert Marciniak, M.D.San Antonio, TX 782291700889201
Common questions
What is Josephine Amalia Taverna, M.D.'s NPI number?
Josephine Amalia Taverna, M.D.'s National Provider Identifier (NPI) is 1629283833, issued on May 11, 2007. An NPI identifies a provider in billing; it is not a license.
Where is Josephine Amalia Taverna, M.D. located?
The NPPES record lists a practice address at 7979 Wurzbach RD FL 4, San Antonio, TX, 78229. Phone: (210) 450-1143. Providers update this record themselves, so call before visiting.
How can I verify Josephine Amalia Taverna, M.D.'s license?
NPPES lists Texas license number R5478, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Josephine Amalia Taverna, M.D. prescribe under Medicare Part D?
In 2024, Josephine Amalia Taverna, M.D. had 442 Medicare Part D claims for 48 beneficiaries; the average among medical oncology physician prescribers was 703. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.